According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

In this webinar, sponsored by IPG Health, we will explore the role that cell and gene therapies can play in treating rare ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

What are some of the current issues with reimbursing cell and ... has entered into contractual agreements with several gene and cell therapy manufacturers to undertake a roll in executing these ...

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in gene therapy using ... pH found inside cells, demonstrating sufficient ...

CAR T-cell therapies have established themselves as a frequently very successful and overall promising treatment option for various blood cancers for which no other effective therapies are available.

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.